Tango Therapeutics, Inc. (TNGX)
22.84
-0.50
(-2.14%)
USD |
NASDAQ |
Aug 31, 16:00
22.82
-0.02
(-0.09%)
After-Hours: 20:00
Tango Therapeutics Cash from Operations (TTM) : -143.90M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -143.90M |
| March 31, 2026 | -141.55M |
| December 31, 2025 | -138.89M |
| September 30, 2025 | -145.82M |
| June 30, 2025 | -148.25M |
| March 31, 2025 | -135.34M |
| December 31, 2024 | -131.50M |
| September 30, 2024 | -122.32M |
| June 30, 2024 | -120.07M |
| March 31, 2024 | -120.93M |
| December 31, 2023 | -117.98M |
| Date | Value |
|---|---|
| September 30, 2023 | -118.78M |
| June 30, 2023 | -107.26M |
| March 31, 2023 | -114.32M |
| December 31, 2022 | -109.08M |
| September 30, 2022 | -97.72M |
| June 30, 2022 | -99.60M |
| March 31, 2022 | -75.58M |
| December 31, 2021 | -59.53M |
| September 30, 2021 | -60.69M |
| June 30, 2021 | 48.94M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Revolution Medicines, Inc. | -1.223B |
| Erasca, Inc. | -98.02M |
| NovelStem International Corp. | -0.2295M |
| Brainstorm Cell Therapeutics, Inc. | -4.057M |
| Summit Therapeutics, Inc. | -457.02M |